Blue native PAGE (BN-PAGE) uses Coomassie dye rather than denaturing SDS to provide a negative charge to proteins for electrophoresis. As such, it is a useful assay for investigating native supramolecular membrane complexes without the need for cross-linking. As Bak and Bax oligomers form in the mitochondrial outer membrane, and they can be efficiently monitored by BN-PAGE. Furthermore, BN-PAGE performed in conjunction with gel-shift using conformation-specific antibodies can provide additional information regarding the activation state of Bak or Bax in specific membrane complexes. 
Immunoblotting reagents
It is recommended that the antibody used for immunoblotting is raised in a different species from the antibodies used for gel-shift to avoid immunoreactivity with the secondary antibody.
Methanol Mouse embryonic fibroblasts (MEF) or cell line of interest, pretreated with a broad-range caspase inhibitor
The number of cells required will depend on their expression of Bak and/or Bax, but a minimum of 1 × 10 6 cells is recommended as a starting point.
In cells that will be treated with a death stimulus, caspases should first be blocked with a broad-range caspase inhibitor, such as qVD-OPh or z-VAD-fmk (Enzyme Systems).
Native gradient gels (Invitrogen) and appropriate markers Gradient gels are required for BN-PAGE.
Permeabilization buffer <R> Phosphate-buffered saline (PBS) (1×; Ca 2+ -and Mg 2+ -free) (ice-cold) <R> Protease inhibitor cocktail tablets, without EDTA (cOmplete; Roche) (1 tablet/50 mL) Solubilization buffer <R> Tris-glycine buffer with SDS/BME (optional; see Step 11.vi) <R> Tris-glycine/MeOH transfer buffer <R> Supplement transfer buffer with 0.037% SDS for gel equilibration (Step 11.iv).
Equipment
Centrifuge (benchtop) at 4˚C Centrifuge tubes Hemocytometer Polyvinyl difluoride (PVDF) membrane SDS-PAGE apparatus (preferably an old kit as it will be stained with Coomassie dye!) Water bath at 65˚C Western transfer apparatus
METHOD
As needed, a reducing agent such as dithiothreitol (DTT) may be added at a concentration of 2-10 mM throughout sample preparation (Steps 3-8); see Discussion.
Inducing Apoptosis and Permeabilizing Cells 1. Treat cells with an apoptotic stimulus as required.
2.
Harvest the cells by centrifugation at 2500g for 5 min. Wash once in 1 mL of ice-cold 1× PBS. Perform a cell count using a hemocytometer.
3. Centrifuge the cells at 2500g for 5 min and discard the supernatant. Gently resuspend the cell pellet in permeabilization buffer supplemented with 0.025% digitonin and protease inhibitors at 1 × 10 7 cells per mL.
Although not absolutely necessary, this permeabilization step removes cytosolic proteins and therefore reduces background during immunoblotting. It also allows for the addition of conformation-specific antibodies for gel-shift assay.
Antibody Gel-Shift and BN-PAGE 6. Resuspend the membranes in permeabilization buffer (with protease inhibitors but without digitonin). Add 1-2 µg of conformation-specific anti-Bak or anti-Bax antibody or a control antibody to each sample. Incubate on ice for 30 min.
Antibody concentration and time of incubation should be determined empirically.
7.
Centrifuge the samples at 13,000g for 5 min to pellet membranes. Discard the supernatant.
8. Resuspend the membranes in solubilization buffer with 1% digitonin by pipetting rapidly with a P200 pipette. Incubate for 30 min on ice.
We routinely resuspend MEF at 1 × 10 7 cells/mL. This step is critical for the efficient solubilization of the membrane complexes and their resolution on BN-PAGE.
9. Centrifuge the samples at 13,000g for 5 min to pellet debris.
10. Retrieve and transfer the supernatant to a fresh tube. Add 1/0 volume of 10× BN-PAGE loading buffer to each sample.
Do NOT heat the samples, as this will denature the proteins and their complexes and defeats the object of BN-PAGE. As complexes will potentially disassociate on storage, only prepare as much sample as will be run on the day of the experiment.
11. Proceed to BN-PAGE as described by Wittig et al. (2006) followed by immunoblotting.
i. Assemble the native gels in the gel tank. Add anode buffer to the outer chamber of the tank so that it reaches halfway up the gel. Before loading the samples, add sufficient cathode buffer I to fill the "wells only," rather than the whole inner chamber.
This allows you to see the samples as they are loaded and helps prevent displacement of the sample when the tank is finally filled with cathode buffer I.
ii. Load samples alongside native markers.
Load samples as sufficient to detect Bak/Bax by immunoblotting. This will vary depending on cell type and should be established empirically. It is important not to "overload" the gel, as this will reduce the definition of the complexes.
iii. Run gels according to Table 1 . After the Coomassie dye front has migrated a one-third of the way through the separation gel, replace cathode buffer I with cathode buffer II to allow protein visualization and aid subsequent transfer. Run the gel until the Coomassie dye front nears the bottom of the gel Abundant mitochondrial respiratory complexes can be directly visualized postelectrophoresis.
iv. Before transfer, equilibrate the gel in Tris-glycine/MeOH transfer buffer supplemented with 0.037% SDS.
v. Transfer to PVDF membrane as normal. After transfer, stain the blot with Coomassie stain. Destain in 50% methanol/25% acetic acid to more easily visualize the markers.
Coomassie staining and destaining is only compatible with PVDF and not nitrocellulose membranes.
vi. If necessary, incubate the blot for 30 min at 65˚C in Tris-glycine buffer with SDS/BME to denature proteins and aid immunodetection.
See Troubleshooting. The success of BN-PAGE is dependent on recognition of the native conformer of the protein of interest by the immunoblotting antibody, and so a number of antibodies should be tested. In addition, this limitation can be overcome by incubating the immunoblot with SDS and β-mercaptoethanol in Tris-glycine buffer for 30 min at 65˚C to effectively denature the proteins and reveal occluded epitopes (Valentijn et al. 2008) .
DISCUSSION
Bak and Bax oligomers form in the mitochondrial outer membrane (MOM) and thus can be monitored by BN-PAGE (Valentijn et al. 2008; Lazarou et al. 2010; Dewson et al. 2012 ). In our experience, Bak and Bax apoptotic oligomers are stable following solubilization from the MOM in 1% digitonin and subsequent BN-PAGE. It is important to note that the redox conditions within a cell vary depending on the subcellular compartment. The need for the addition of a reducing agent during the sample preparation will depend on the native environment of the complexes under investigation. For example, if the complex is exposed to the reducing environment of the cytosol, as with Bak and Bax, then addition of DTT is recommended to prevent artifactual disulphide-bonding during membrane solubilization that will alter the complexes detected on BN-PAGE. If required, DTT should be added at a concentration of 2-10 mM "throughout" sample preparation (Steps 3-8). 
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